Sportradar Group AG, together with its subsidiaries, provides sports data services for the sports betting and media industries in Switzerland, the United States, North America, Africa, Malta, the Asia Pacific, the Middle…
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.12, read 2026-11-03
Ethical passes the values gate
Price14.49 USD
Fair value14.24
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-10-28Read Markup11.99+20.9% to today ✓Distribution gives way to Markup after a 7% slide in 6 weeks
2026-09-13Read Distribution12.95+11.9% to today Markup gives way to Distribution after a 19% slide in 10 weeks
2026-07-02Read Markup15.99-9.4% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Sportradar Group AG holds its Markup at $14.49. The statistical read favours the buyers, held for 4 days.
As held on the ledger · 2026-11-04
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 4 days
Price at the screen
$14.49
Valuation
207.00 trailing · 31.08 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.63
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
2.19%
Below 33%
Interest-bearing debt is just 2.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.42%
Below 33%
Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit.
Pass
Receivables
15.97%
Below 49%
Money owed to the company is 16.0% of assets, under the 49% limit.
Pass
Revenue purity
0.75%
Below 5%
Only 0.8% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Sportradar clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 2%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SRAD's ethical verdict changes
Today SRAD passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades above our $14.24 fair value estimate, 18.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 1.8% above the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $14.24, with a range of $11.70 to $16.38, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
The quiet data feed behind every bet
Picture the referee's whistle that also keeps the score for every bookmaker in the room. Sportradar supplies the sports data that powers betting platforms and media rights, yet the business earns only a 5% profit margin and a 7% return on equity while growing revenue at 11%. At 18 times forward earnings the valuation already prices in steady improvement that the current numbers do not support.
The 40% gap to our fair value looks attractive on paper and the ethical screen is clear, but opportunity rating sits at none. Low returns and thin margins suggest the company lacks a durable edge in a crowded data market, even with twenty-one analysts calling the shares a strong buy.
Currency moves, regulatory shifts on betting and the unknown competitive moat add real volatility that a low-teens growth rate does not offset. The setup is neither compelling nor cheap enough once quality is weighed. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Switzerland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SRAD trades on Nasdaq (the company is based in Switzerland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup$14.20+18.4%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21. Insiders have been net sellers over the past quarter.
2026-10-28Markup · changed$11.99+0.0%Entry 9
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21. Insiders have been net sellers over the past quarter.
2026-10-21Distribution$11.99-4.0%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21. Insiders have been net sellers over the past quarter.
2026-10-14Distribution$12.49-0.4%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
2026-10-02Distribution$12.54-3.2%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
2026-08-13Markup$13.02-18.6%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 18.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
2026-07-18Markup$15.99+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 31%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it strong buy, with a mean price target of $21.
2026-07-03Markup$15.99+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markup$15.99Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
